Navigation Links
Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation
Date:12/14/2007

- Key Architect of Foundation's Strategy Will Build On and Expand Transformational Approach -

NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced the appointment of Katie Hood as chief executive officer.

Ms. Hood, who joined the Foundation in September 2002, has been serving as interim CEO since October. As chief executive officer, she will build on the Foundation's strategy of inserting itself proactively into the research process to advance scientific breakthroughs, including the expansion of current initiatives to:

-- validate promising drug targets, thereby opening new opportunities for drug development;

-- increase investment in various stages of pre-clinical research and chaperoning pre-clinical hits from stage to stage;

-- selectively support clinical projects with the potential to improve patients' lives in the near-term; and

-- drive high-risk, high-reward attempts to uncover new research tools such as biomarkers.

Ms. Hood stated, "The Michael J. Fox Foundation has evolved into an organization willing to do whatever it takes to accelerate life-transforming treatments for Parkinson's patients - going beyond innovative funding mechanisms to work to change a flawed system that too often fails to translate research into results. Over the past seven years, we have built a unique expertise about Parkinson's research that we intend to leverage for impact over the coming months and years. Our capital should be -- and will be -- used to drive progress in ways that other funding sources are not."

David Golub, chairman of the Board of Directors of The Michael J. Fox Foundation, said: "We are committed to a strategy of working relentlessly to close critical gaps in the process of moving potential treatments from the laboratory to Parkinson's patients, and have worked with Katie and the entire executive team to develop a compell
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
4. William Moore Appointed to IRIDEX Board of Directors
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
7. James B. Hawkins Appointed to IRIDEX Board of Directors
8. Bryan R. Rogers Appointed President of Far West Division
9. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
10. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
11. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)... Colo., Nov. 21 Heska Co...ll present at the New York Society of,Security An...onference on,December 2, 2008 at 1177 Avenue of t...ntation is scheduled to begin at 9:35 a.m. Eastern...able via live webcast and for two weeks,following...
(Date:11/21/2008)...rchers remain cautious about future antibiotic res..., Nov. 21 (HealthDay News) -- People with moderate...COPD) may be able to reduce the frequency of exace...ntibiotic, a new report says. , The study, pub...rican Journal of Respiratory and Critical Care Med...
(Date:11/21/2008)...Nov. 21 The University... beginning of a collaborative effort to eradicate ...r Breast Cancer Awareness and Research of the Amer...Lady of the United States, and Vivian Fernandez de...ining M. D. Anderson in the initiative are the U.S...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...transvaginal ultrasound scans can do away with inv... tests, used for determining// a woman’s success r...Kwee from Vrije Universiteit Medical Center in Ams...e ovaries of women subjects in an IVF program. ...
...re consuming very little of vegetables and fruits ...d other ailments//. This was disclosed by Heidi Bl... Blanck found that 32.6% of the respondents had fr...umed vegetables thrice or more than thrice per day...
...health caused by an unintentional injury or new ch...likely to have difficulty// obtaining recommended ...declines in short-term health, according to a stud...nstitute, Washington, D.C., presented the results ...
...rary of Science) suggests that computers could gue...lating// the wishes of a terminally sick patient. ...tumbled upon this finding while he was analyzing t...ne on the course of action involving a critically ...
Other Medicine News:Health News:Cheaper and Quicker Alternative to Ovarian Reserve Tests 2Health News:Uninsured Often Receive Less Medical Care 2
(Date:11/20/2008)...PRNewswire-USNewswire/ -- The following is being r..., , WHAT: World AIDS Day Audio Media Conf... 25, 2008 , 11:00 a.m. EST , Call-in number:...tps://cc.readytalk.com/r/1xe41i2yre8rs , , ...er of people newly put on treatment worldwide, adv...
(Date:11/20/2008)...and, November 20 Arpida ...ve Drugs Advisory Committee of the,U.S. Food and ...t the,approval of intravenous iclaprim, an antibi...f patients with complicated skin and skin structur...methicillin-resistant Staphylococcus,aureus (MRSA...
(Date:11/20/2008).... 20 Radius Health ("Radius") anno...illion to its second institutional financing round...llion and the total amount raised since the compan...itutional investors participated in the financing,...g MPM Capital, The Wellcome Trust, HealthCare Vent...
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Faulty brain connections may be responsible for social impairments in autism 21702 1Faulty brain connections may be responsible for social impairments in autism 21702 2Centromeres cross over a lot 3624 1Study pinpoints strategies that protect older adults physical health 21700 1Study pinpoints strategies that protect older adults physical health 21700 2Carnegie Mellon researchers improve assessments of aortic aneurysms 21698 1Carnegie Mellon researchers improve assessments of aortic aneurysms 21698 2
...ticipates second quarter BLA filing for C1-inhibit...PRNewswire-FirstCall/ -- Lev,Pharmaceuticals, Inc....ivotal U.S. Phase III trial of C1-esterase inhibit...angioedema (HAE). In the,acute study, which is par...Hereditary Angioedema Nanofiltration Generation,ev...
...Calif.--(BUSINESS WIRE)--Mar 15, 2007 - A small cl...has failed to find any,conclusive benefit for pati...ng to researchers at the Stanford University,Schoo...sibility that some,medications, including the one ...for certain patients. , More than 1.2 million peop...
Other Medicine Technology:Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5Stanford Study Finds No Conclusive Benefit From Treating,Kleptomania With Medication 2
...erior Chamber Lenses: The Bausch & Lomb PMMA Poste... used for primary implantation for the visual corr...lder where a cataractous lens has been removed by ... intended to be placed in the ciliary sulcus or ca...
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Multipiece PMMA IOL - Sulcus Fixation.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Medicine Products: